Skip to main content
All lobbying filings

MR. DAN CRIPPEN

Lobbying for AMGEN · Manufacture Pharmaceuticals

 Filing Registration
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted May 7, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia

Official filing document

 Lobbying activity 1
Pharmacy

pharmacy pricing, R&D, chronic disease

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem